New developments in Genome Editing Technologies give a push to its demand

Aarkstore Market Research entitles the new approach into a Market Research Report “Genome Editing: Technologies And Global Markets” Summary Genome editing is a revolutionary technology in the biotechnology and medical fields. It is changing many related areas that form the genome editing market. The global market for genome editing was estimated at $REDACTED billion inContinue reading “New developments in Genome Editing Technologies give a push to its demand”

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021. On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, flow cytometry, single-use bioprocessing, cell line development, virusContinue reading “The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021”

Vaccines Market by Technology , Disease Indication , End User & Type – Forecasts to 2021

Summary: The vaccines market is expected to reach USD 48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market,Continue reading “Vaccines Market by Technology , Disease Indication , End User & Type – Forecasts to 2021”

Global Biosimilars Market Value Could Hit $55 Billion by 2020

Biosimilars – Regulatory Framework and Pipeline Analysis The value of the global biosimilars market is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active developments and government efforts to reduce healthcare spending. Biologics currently account for betweenContinue reading “Global Biosimilars Market Value Could Hit $55 Billion by 2020”